Product News: Colorcon launches on-dose authentication technology platform for drug manufacturing

New platform could significantly reduce risks associated with counterfeit and falsified medications entering supply chains

03 Jan 2020


Colorcon, a leader in the development and supply of film coating systems and excipients, announces the development and availability of On-Dose Authentication capability to provide track and trace functionality for supply chain security.  

The seamless integration of molecular taggants from Applied DNA Sciences (ADNAS) into an Opadry® fully formulated film coating system significantly reduces the risks associated with counterfeit and falsified medications entering the supply chain.

This first commercial offering is the culmination of extensive collaboration between Colorcon and ADNAS to help pharmaceutical companies enhance patient safety and reduce risk by using intelligent data and analytics gathered from authentication of the dosage form itself. By better understanding the vulnerabilities of a complex global supply chain, drug manufacturers can make informed decisions regarding distribution networks and deploy preventative measures to address counterfeiting and product diversion issues.

Dr. Ali Rajabi-Siahboomi, Vice President/Chief Scientific Officer at Colorcon Inc. says “With new guidelines from regulators and accessible technology, on-dose solutions provide a more robust and reliable means of identifying and deterring counterfeiting, verifying product authenticity, and ensuring product traceability. Through extensive research and development, Colorcon has created a unique coating system to address this global problem.” 

Kelly Boyer, General Manager, Film Coatings at Colorcon Inc. explains “On-dose authentication technology represents the next generation in pharmaceutical supply-chain security by providing a powerful tool for tracking product from plant to patient. By seamlessly enabling authentication, these digitized coatings confirm the quality and origin of medicines thereby safeguarding both patients and brands.”

Colorcon continues to advance technologies and services to meet industry challenges with innovative solutions. This latest technology demonstrates Colorcon’s approach to responding to the needs of the pharmaceutical industry, bringing novel solutions that are efficient and deliver with dependable performance. 

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>